Avi Shvarts

1.3k total citations · 1 hit paper
18 papers, 1.1k citations indexed

About

Avi Shvarts is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Avi Shvarts has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Genetics and 6 papers in Cancer Research. Recurrent topics in Avi Shvarts's work include Cancer-related Molecular Pathways (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Virus-based gene therapy research (5 papers). Avi Shvarts is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Virus-based gene therapy research (5 papers). Avi Shvarts collaborates with scholars based in Netherlands, United States and Russia. Avi Shvarts's co-authors include P. J. van Diest, Petra van der Groep, Elsken van der Wall, Astrid E. Greijer, Reinhard Bos, Herbert M. Pinedo, Gregg L. Semenza, Sybren Meijer, Wilma T. Steegenga and René Bernards and has published in prestigious journals such as Genes & Development, Nature Cell Biology and Molecular and Cellular Biology.

In The Last Decade

Avi Shvarts

17 papers receiving 1.1k citations

Hit Papers

Levels of hypoxia‐inducible factor‐1α independently predi... 2003 2026 2010 2018 2003 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Avi Shvarts Netherlands 11 717 532 491 183 151 18 1.1k
Victoria J. Heath United Kingdom 8 690 1.0× 645 1.2× 264 0.5× 150 0.8× 109 0.7× 10 1.2k
Sétha Douc‐Rasy France 20 987 1.4× 528 1.0× 296 0.6× 128 0.7× 115 0.8× 38 1.4k
Daniel Chua Hong Kong 22 823 1.1× 671 1.3× 449 0.9× 174 1.0× 67 0.4× 28 1.5k
Yari Ciribilli Italy 23 983 1.4× 521 1.0× 319 0.6× 131 0.7× 72 0.5× 54 1.3k
Susan M. Mendrysa United States 13 1.1k 1.5× 859 1.6× 212 0.4× 69 0.4× 167 1.1× 18 1.4k
James Koh United States 16 944 1.3× 800 1.5× 242 0.5× 163 0.9× 90 0.6× 35 1.5k
Jean‐Gabriel Judde France 19 581 0.8× 946 1.8× 363 0.7× 115 0.6× 132 0.9× 42 1.5k
Laura R. Livingstone United States 6 1.0k 1.4× 852 1.6× 297 0.6× 154 0.8× 220 1.5× 8 1.4k
Linda C. Harris United States 22 1.2k 1.7× 522 1.0× 349 0.7× 164 0.9× 68 0.5× 44 1.4k
Hena R. Ashar United States 12 1.2k 1.6× 522 1.0× 380 0.8× 177 1.0× 44 0.3× 13 1.6k

Countries citing papers authored by Avi Shvarts

Since Specialization
Citations

This map shows the geographic impact of Avi Shvarts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avi Shvarts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avi Shvarts more than expected).

Fields of papers citing papers by Avi Shvarts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avi Shvarts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avi Shvarts. The network helps show where Avi Shvarts may publish in the future.

Co-authorship network of co-authors of Avi Shvarts

This figure shows the co-authorship network connecting the top 25 collaborators of Avi Shvarts. A scholar is included among the top collaborators of Avi Shvarts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avi Shvarts. Avi Shvarts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
4.
Shvarts, Avi, et al.. (2012). An Evaluation of Pneumococcal Titers in Patients receiving Ig replacement for Immunodeficiency. Journal of Allergy and Clinical Immunology. 129(2). AB84–AB84. 1 indexed citations
5.
Piek, Jurgen M.J., Josephine C. Dorsman, Leon F.A.G. Massuger, et al.. (2006). BRCA1 and p53 protein expression in cultured ovarian surface epithelial cells derived from women with and without a BRCA1 germline mutation. Archives of Gynecology and Obstetrics. 274(6). 327–331. 2 indexed citations
6.
Groot, Arjan J., Peter Verheesen, Eelke Gort, et al.. (2006). Identification by phage display of single-domain antibody fragments specific for the ODD domain in hypoxia-inducible factor 1alpha. Laboratory Investigation. 86(4). 345–356. 33 indexed citations
7.
Piek, Jurgen M.J., Josephine C. Dorsman, Avi Shvarts, et al.. (2004). Cultures of ovarian surface epithelium from women with and without a hereditary predisposition to develop female adnexal carcinoma. Gynecologic Oncology. 92(3). 819–826. 10 indexed citations
8.
Bos, Reinhard, P. J. van Diest, Petra van der Groep, et al.. (2004). Expression of hypoxia-inducible factor-1α and cell cycle proteins in invasive breast cancer are estrogen receptor related. Breast Cancer Research. 6(4). R450–9. 67 indexed citations
9.
Edel, Michael J., Avi Shvarts, Jan Paul Medema, & René Bernards. (2004). An in vivo functional genetic screen reveals a role for the TRK-T3 oncogene in tumor progression. Oncogene. 23(29). 4959–4965. 8 indexed citations
10.
Bos, Reinhard, P. J. van Diest, Petra van der Groep, et al.. (2003). Protein expression of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer is associated with cyclin D1 and hypoxia-inducible factor-1α (HIF-1α). Oncogene. 22(55). 8948–8951. 52 indexed citations
11.
Bos, Reinhard, Petra van der Groep, Astrid E. Greijer, et al.. (2003). Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer. 97(6). 1573–1581. 413 indexed citations breakdown →
12.
Peeper, Daniel S., Avi Shvarts, Thijn R. Brummelkamp, et al.. (2002). A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence. Nature Cell Biology. 4(2). 148–153. 91 indexed citations
13.
Shvarts, Avi, Thijn R. Brummelkamp, Ferenc A. Scheeren, et al.. (2002). A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19 ARF –p53 signaling. Genes & Development. 16(6). 681–686. 127 indexed citations
14.
Steegenga, Wilma T., Avi Shvarts, Nicole Riteco, Johannes L. Bos, & Aart G. Jochemsen. (1999). Distinct Regulation of p53 and p73 Activity by Adenovirus E1A, E1B, and E4orf6 Proteins. Molecular and Cellular Biology. 19(5). 3885–3894. 84 indexed citations
15.
Shvarts, Avi, Merlijn Bazuine, Patrick Dekker, et al.. (1997). Isolation and Identification of the Human Homolog of a New p53-Binding Protein, Mdmx. Genomics. 43(1). 34–42. 124 indexed citations
16.
Steegenga, Wilma T., Theo van Laar, Nicole Riteco, et al.. (1996). Adenovirus E1A Proteins Inhibit Activation of Transcription by p53. Molecular and Cellular Biology. 16(5). 2101–2109. 66 indexed citations
17.
Steegenga, Wilma T., Theo van Laar, Avi Shvarts, et al.. (1995). Distinct Modulation of p53 Activity in Transcription and Cell-Cycle Regulation by the Large (54 kDa) and Small (21 kDa) Adenovirus E1B Proteins. Virology. 212(2). 543–554. 26 indexed citations
18.
Zhuang, Shi‐Mei, et al.. (1995). Differential sensitivity to Ad5 E1B-21kD and Bcl-2 proteins of apoptin-induced versus p53-induced apoptosis. Carcinogenesis. 16(12). 2939–2944. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026